RxDoctor Payments Data

Nadim Geloo

Interventional Cardiology · Falls Church, VANPI 1467432146

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $29,281 of the $41,435 with a category attached, or 70.7%. Medtronic accounts for 88.1% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2020 at $21,176 and has fallen 98.5% since, to $323 in 2022.

$41,435in general payments, 2019–2025

Across 179 payments — averaging $231.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$37K
  • Abbott$4K
  • Cardiovascular Systems Inc.$287
  • Biotronik Inc.$164
  • AstraZeneca$159
  • Abiomed$145
  • plus $333 from 11 others

What the payments were for

  • Speaking & faculty fees$29,28171%
  • Travel & lodging$8,07419%
  • Food & beverage$4,08010%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$41,435 in reported general payments places this provider in the 85th percentile of 176 interventional cardiology providers in Virginia.

See all interventional cardiology providers in Virginia

Other interventional cardiology in Falls Church

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →